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Purpose: To determine the effect of penetrating ocular injury on the induction of anterior chamber-associated immune
deviation (ACAID).
Methods: An injection of 5 μl ovalbumin (OVA, 20 mg/ml) into the anterior chamber (AC) of female BALB/c mice was
performed to induce ACAID. A penetrating ocular injury was induced via the limbus on OVA-inoculated eyes at 24 h,
48 h, 72 h, and 120 h following AC injection. The mice receiving an OVA inoculation without the ocular injury served
as the AC-injection group. Delayed type hypersensitivity (DTH) was examined to evaluate the induction of ACAID. The
levels of transforming growth factor (TGF)-β1, interleukin (IL)-10, and interferon (IFN)-γ produced by splenocytes were
detected by enzyme-linked immunosorbent assays (ELISA). The frequency of CD4+CD25+Foxp3+T cells in the
splenocytes was detected by flow cytometry.
Results: A significantly decreased DTH response was observed in the AC-injection group as well as in mice that received
a penetrating injury at 72 h and 120 h following AC-injection of OVA. The levels of TGF-β1 and IL-10 produced by
splenocytes of mice in the AC-injection group and in the 72-h and 120-h group were significant higher than those in the
24-h and 48-h group. However, the levels of IFN-γ produced by splenocytes of the AC-injection group and the 72-h and
120-h group were significantly lower than those in the 24-h and 48-h group. An increased frequency of
CD4+CD25+Foxp3+T cells was found in the AC-injection group and the 72-h and 120-h group.
Conclusions: Penetrating ocular injury preformed shortly (24 h-48 h) after an AC injection of an antigen was able to
abrogate ACAID and was associated with a decreased production of TGF-β1 and IL-10, an increased production of IFN-
γ, and a decreased expression of CD4+CD25+Foxp3+T cells.
Systemic immune tolerance induced by injecting
exogenous antigens (Ag) into the anterior chamber of the eye
is called anterior chamber-associated immune deviation
(ACAID) [1,2]. It is characterized by elevated serum levels of
Ag-specific, noncomplement fixing antibodies, expanded
clones of precursor cytotoxic T cells, and impaired Ag-
specific delayed–type hypersensitivity (DTH) [3,4]. This
phenomenon is important in protecting the eye from bystander
damage of inflammation and in maintaining an immune
privileged microenvironment within the eye [5,6].
The mechanisms involved in the development of ACAID
have been studied for many years. Several factors, including
the local immune microenvironment of the eye [7], the
integrity of the eye-spleen axis [4,8,9], and the local anatomic
integrity of the eye [10], have been shown to contribute to the
induction of ACAID. Earlier studies have shown that
enucleation of antigen-inoculated eyes three to four days after
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anterior chamber (AC) inoculation was able to prevent
ACAID induction [11]. An AC injection of antigen using a
30-gauge needle and not 33-gauge needle could induce
ACAID [12]. This suggested that a certain degree of injury
leading to intraocular tumor necrosis factor (TNF) production
was needed to induce ACAID. However, ACAID could not
be induced in mice if corneal lesions were applied using an
electrocautery [13]. The observations mentioned above
suggest that the degree of ocular injury may have profound
consequences on the expression of ocular immune tolerance.
To further examine the mechanisms involved in maintaining
ocular immune privilege, we developed a new experimental
injury model in mice. Using this model, we show the
involvement of CD4+CD25+Foxp3+T cells and three
cytokines, transforming growth factor (TGF)-β1, interleukin
(IL)-10, and interferon (IFN)-γ, in the development of
ACAID.
METHODS
Animals: Forty-eight specific, pathogen-free, female BALB/
c mice (six to eight weeks old) were used in the experiments.
Six mice were used in each group as listed below. Mice were
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327purchased from the Guangdong Medical Laboratory Animal
Center. All mice were treated according to the ARVO
Statement for the Use of Animals in Ophthalmic and Vision
Research.
Induction of ACAID and preparation of penetrating ocular
injury: ACAID was induced as described previously [14-16].
Mice were anesthetized with inhalation anesthesia consisting
of oxygen and 1.7% isoflurane. Five microliters of ovalbumin
(OVA; 20mg/ml; Sigma-Aldrich, Steinheim, Germany)
dissolved in phosphate buffered saline (PBS) were injected
into the AC of mice using a glass micropipette (about 80 μm
in diameter) with a sterile infant feeding tube mounted onto a
0.1 ml Hamilton syringe (Hamilton, Reno, NV). Seven days
later, the mice were immunized by subcutaneous (s.c.)
injection of 250 μg OVA (2.5mg/ml, dissolved in PBS)
emulsified 1:1 in complete Freund’s adjuvant (CFA; Sigma-
Aldrich). This group of mice acted as the AC-injection group.
Mice receiving an s.c. injection of OVA in CFA alone acted
as positive controls. Untreated mice acted as normal controls.
Mice receiving an injection of 5 μl sterile PBS into the anterior
chamber and an s.c. injection of OVA in CFA seven days after
AC injection acted as PBS controls. A penetrating ocular
injury on OVA-inoculated eyes was performed 24 h (24-h
group), 48 h (48-h group), 72 h (72-h group), and 120 h (120-
h group) after AC injection. A 1 mm-depth penetrating ocular
injury was made using a modified Standard Angle Blade
(Alcan Laboratory, Fort Worth, Texas) as described below. A
copper sheet was attached 1 mm posterior to the blade tip
using metal gel to prevent a deeper injury (Figure 1A). Under
a microscope, a perpendicular injury was carefully performed
at the six o’clock position of the limbus using this modified
blade (Figure 1B). Iris incarceration was observed in the eye
immediately after this procedure had been performed. All
mice were challenged with an s.c. injection of OVA in CFA
seven days after the AC injection of OVA.
Delayed type hypersensitivity assay: Seven days after s.c.
immunization, the mice were challenged with an intradermal
injection of 20 μl OVA (20 mg/ml) into the left ear pinna. The
right ear pinna received an intradermal injection of 20 μl
sterile PBS. Both ear pinnae were measured with a Mitutoyo
engineer’s micrometer (MTI Corp, Paramus, NJ) before (0 h)
and 24 h after the intradermal injection of OVA. The following
formula was used to evaluate the DTH response: specific ear
pinnae swelling= (24 h measurement-0 h measurement) of left
ear- (24 h measurement- 0 h measurement) of right ear
[17-19].
Cytokine assay by enzyme-linked immunosorbent assay: Mice
were sacrificed seven days after s.c. injections. Spleens were
removed and grinded to prepare a single-cell suspension by
density gradient centrifugation. The cells were incubated in a
complete RPMI 1640 medium (Gibco, Grand Island, NY)
with OVA (100 μg/ml for TGF-β1 measurement and 200 μg/
ml for IL-10 and IFN-γ measurement) for 48 h in 24-well
culture plates (2 10 6 for TGF-β1 measurement and 4 10 6
cells/well for IL-10 and IFN-γ measurement). The
supernatants were collected for the measurement of TGF-β1,
IL-10, and IFN-γ by enzyme-linked immunosorbent assays
(ELISA) kits (R&D system, Minneapolis, MN).
Detection of the frequency of CD4+ CD25+ Foxp3+ T cells in
splenocytes by flow cytometry: Splenocytes were separated
from the spleens of mice obtained from each group, and the
frequency of CD4+ CD25+ Foxp3+ T cells was analyzed by
BD FACSAria (BD Biosciences, San Jose, CA) using the BA
FACDiVa software (BD Biosciences) in accordance with the
manufacturer’s instructions. Briefly, 1 10 6 splenocytes were
first incubated with FITC-anti mouse CD3 monoclonal
antibody (mAb; BD PharMingen, San Diego, CA),
phycoerythrin (PE)-anti mouse CD4 mAb (eBioscience, San
Diego, CA), and PE-cy7 anti mouse CD25 mAb (eBioscience)
at 4 °C for 30 min. Cells were washed, fixed, and
permeabilized using fixation/permeabilization buffer
(eBioscience) at 4 °C for 1 h. Staining was performed with
APC-anti mouse Foxp3 mAb (eBioscience) at 4 °C for 30 min,
and the cells were washed, resuspended, and finally subjected
to flow cytometry (FCM) for analysis. Cells stained with PE-
cy7-conjugated rat immunoglobulin G1 (IgG1; eBioscience)
or APC-conjugated rat IgG2a (eBioscience) served as isotype
controls.
Statistics: The results were expressed as mean ± standard error
of the mean (SEM). Data were analyzed by analysis of
variance (ANOVA) using SPSS 10.0. A value of p<0.05 was
considered a significant difference.
Figure 1. The method for preparation of a 1 mm-depth penetrating
ocular injury at six o’clock of the murine limbus. A modified
Standard Angle Blade is shown in the picture (A). A copper sheet
was stuck 1 mm posterior to the blade tip. The diagram (B) showed
that a 1 mm-depth penetrating ocular injury was made
perpendicularly to the limbus using the modified standard Angle
Blade.
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Delayed type hypersensitivity responses at different groups:
As the absence of a DTH response is a typical characteristic
of ACAID [20], it was used as an index for the induction of
ACAID in this study. The results showed that the DTH
response was significantly suppressed in the AC-injection
group and normal controls compared to the positive controls
(both p<0.001). However, a marked DTH response
comparable with that in positive controls was observed in
animals that had received a penetrating ocular injury at 24 h
and 48 h following AC injection of OVA but not in the 72 h
or 120 h group. Similarly, a strong DTH response was also
noted in the PBS control group (Figure 2).
Expression of IFN-γ, TGF-β1, and IL-10 at different groups:
As cytokines, such as TGF-β1, IL-10, and IFN-γ, were
involved in the induction of ACAID [21-25], our study
examined whether there was an alteration in the production of
these cytokines in the penetrating ocular injury groups. As
shown in Figure 3, Figure 4, and Figure 5, the production of
TGF-β1 and IL-10 was low and IFN-γ was undetectable in
Figure 2. Delayed type hypersensitivity measurements were
performed after an anterior chamber injection of ovalbumin. Mice
that were immunized via an s.c. injection of OVA in CFA seven days
after AC injection of OVA acted as the AC-injection group. Mice
received a penetrating ocular injury 24 h (24-h group), 48 h (48-h
group), 72 h (72-h group), or 120 h (120-h group) after an AC
injection of OVA on the OVA-inoculated eyes. This was followed
by an s.c. injection of OVA in CFA seven days after the AC injection
of OVA. Mice without any treatment acted as normal controls. Mice
immunized only with OVA in CFA acted as the positive controls.
Mice receiving an AC injection of sterile PBS and an s.c. injection
of OVA in CFA seven days after the AC injection acted as PBS
controls. All mice received an ear challenge seven days after s.c.
immunization. Both ear pinnae were measured before (0 h) and 24 h
after the ear challenge. Mean ± SEM ear-swelling responses are
presented (n=6 per group). The asterisk indicates that p<0.05 when
compared with the positive control.
normal mice. An increased production of TGF-β1 and IL-10
and a low production of IFN-γ was observed in the AC-
injection group compared to the positive controls (p<0.001,
p=0.032, and p=0.005, respectively). The production of these
cytokines was not different between the positive controls and
PBS controls. A higher production of TGF-β1 and IL-10 and
a lower production of IFN-γ were found in the 72-h and 120-
h group. However, a decreased production of TGF-β1 (both
p<0.001) and IL-10 (p=0.009, p=0.013, respectively) and an
increased production of IFN-γ (p=0.001, p=0.008,
respectively) were detected in the 24-h and 48-h group
compared to the AC-injection group.
Effect of ocular injury on the frequency of CD4+ CD25+
Foxp3+ T cells in splenocytes of ACAID mice: An earlier study
has shown that the CD4+ CD25+ Foxp3+ subpopulation of T
cells play an important role in immune tolerance [26]. In this
study, we examined the frequency of CD4+ CD25+ Foxp3+ T
cells in splenocytes in ACAID mice with or without an ocular
injury and compared the data with appropriate controls. Our
results showed that a significantly higher frequency of
CD4+CD25+Foxp3+T cells was observed in the AC-injection
group as compared with the normal controls, PBS controls,
and positive controls (all p<0.001). A result similar to that in
the AC-injection group was also noted in animals that had
received an ocular injury 72 h or 120 h following AC injection
of OVA. However, the frequency of these cells did not
increase in the 24-h or 48-h “injury” groups (both p<0.001
versus AC-injection group; Figure 6).
Figure 3. Detection of TGF-β1 produced by splenocyte. Mice were
sacrificed seven days after s.c. immunization. Spleens were removed
and grinded to prepare a single-cell suspension. These cells were
incubated in a complete RPMI 1640 medium with OVA (100 μg/ml)
for 48 h in 24-well culture plates (2 10 6 cells/well). Supernatants
were collected for determining the quantity of TGF-β1 by ELISA.
Data are the mean ± SEM (n=6 per group). The asterisk indicates that
p<0.05 as compared with the positive control.
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In this study, we injected OVA into the AC of mice and used
the DTH response to evaluate the development of ACAID.
The results showed that an AC injection of OVA could induce
a decreased DTH response in association with an increased
production of TGF-β1 and IL-10, an increased frequency of
CD4+CD25+Foxp3+T cells, and a decreased production of
IFN-γ. A penetrating ocular injury 24 h and 48 h following
AC injection led to a marked DTH response, a downregulation
of TGF-β1, IL-10, and CD4+CD25+Foxp3+T cells, and an
upregulation of IFN-γ. These results suggest that a penetrating
ocular injury at an early stage following an AC injection of
OVA could prevent the induction of ACAID and that TGF-
β1, IL-10, IFN-γ, and CD4+CD25+Foxp3+T cells may be
involved in this process.
The ACAID model has received a great deal of attention
in recent years mainly due to its physiologic and pathologic
implications. Under normal conditions, antigens administered
into the anterior chamber of the eye did not elicit a DTH
response thereby protecting the eye from bystander damage
of inflammation. However, ACAID can temporarily be
circumvented by specific autoantigens (in combination with
immunological adjuvants) or by following a systemic
lipopolysaccharide injection that leads to severe intraocular
inflammation [27]. The disruption of the integrity of the eye
may also inhibit this immune tolerance and induce an
intraocular inflammation. Sympathetic ophthalmia as seen in
human patients is presumably mediated by an immune
response to certain antigens (i.e., abortion of ACAID) due to
Figure 4. Detection of IL-10 produced by splenocytes. Spleens from
each group of mice were harvested seven days after s.c.
immunization and were used for preparing a single-cell suspension.
The cells were incubated in a complete RPMI 1640 medium with
OVA (200 μg/ml) for 48 h in 24-well culture plates (4 10 6 cells/
well). IL-10 in supernatants was quantified by ELISA. Data are the
mean ± SEM (n=6 per group). The asterisk means that p<0.05 as
compared with the positive control.
the disruption of ocular integrity following penetrating ocular
injury or intraocular surgery [28]. In this study, we examined
whether and when a penetrating ocular injury influenced the
induction of ACAID. As the absence of a DTH response is a
crucial characteristic in ACAID, we evaluated the induction
of ACAID by measuring the DTH response in mice following
various treatments. The results showed that a DTH response
was readily detected in positive controls and PBS controls but
not in the AC-injection group or in the normal, untreated
controls. A significant DTH response was also observed in the
24 h and 48 h “injury” group but not in the 72-h and 120-h
group. These results indicate that the breakdown of the eye’s
integrity at an early stage following an AC injection could
induce a DTH response and was able to prevent the induction
of ACAID. Our finding is consistent with experiments where
the enucleation of an Ag-inoculated eye within 72 h of the AC
injection prevented ACAID induction [29].
Earlier studies have shown that induction of ACAID is
the result of a T helper cell 2 (Th2)-like response [30,31]. IFN-
γ has been shown to inhibit the proliferation of Th2 cells,
whereas IL-10 profoundly inhibits the production of Th1
cytokines [32]. It has been reported that an increased
expression of TGF-β and IL-10 and a decreased expression of
IFN-γ was associated with ACAID [31,33,34]. In this study,
we examined whether a penetrating ocular injury influenced
the production of these cytokines and if a relationship existed
between the development of ACAID and the production of
these cytokines. Our results showed that TGF-β1 and IL-10
were significantly upregulated while IFN-γ was markedly
Figure 5. Detection of IFN-γ produced by splenocytes. Splenocytes
were obtained from each group of mice seven days after s.c.
immunization. The cells were incubated in a complete RPMI 1640
medium with OVA (200 μg/ml) for 48 h in 24-well culture plates
(4 10 6 cells/well). The levels of IFN-γ in supernatants were
determined by ELISA. Data are the mean ± SEM (n=6 per group).
The asterisk indicates that p<0.05 when compared with the positive
control. The hash mark means that the production of IFN-γ was lower
than the detection limit of the assay.
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330downregulated in the AC-injection group. These results are
consistent with previously reported findings [31,33,34]. It is
interesting to observe that a penetrating ocular injury 24 h or
48 h after an AC injection of OVA could lead to a decreased
production of TGF-β1 and IL-10 and an increased production
of IFN-γ, whereas a penetrating ocular injury at 72 h or later
did not influence the profile of these cytokines. These results
showed that there was a negative correlation between DTH
response and the expression of TGF-β1 and IL-10 and that a
positive association exists between DTH response and IFN-
Figure 6. Flow cytometry analysis of CD4+CD25+Foxp3+T cells.
Flow cytometry analysis of CD4+CD25+Foxp3+T cells per 1 106
splenocytes in mice from different groups. The mice in the groups
listed as AC-injection 24h, 48h, 72h, 120h, normal controls, and PBS
controls were as same as described in Figure 2. Spleens from
different groups were removed 7 days after s.c. immunization and
used for preparing a single-cell suspension. The cells were stained
with anti-CD3, anti-CD4, anti-CD25, and anti-Foxp3 mAb. Data in
A indicate the percentage of CD25+Foxp3+ cells which derive from
gating on CD3+ CD4+ cells. The results shown in the histogram
(B) are the mean SEM (n=6 per group). The asterisk indicates that
p<0.05 when compared with the positive control.
γ expression. These results suggest that the cytokines that are
downregulated by a penetrating ocular injury during the early
phase after an AC injection of OVA are probably involved in
the development of ACAID. It is worthy to point out that an
interesting result has been observed by Obta et al [35]. They
found that IL-6 was able to prevent the development of
ACAID when injected concurrently with an antigen into the
anterior chamber. It has been shown that IL-6 is produced
following viral/bacterial infection and corneal transplantation
[36,37]. These results raise questions whether IL-6 is locally
induced following a penetrating ocular injury and whether an
increased level of IL-6 is involved in the abortion of ACAID.
Further studies are needed to clarify these issues.
It has been reported that CD4+CD25+ regulatory T cells
are important for the induction and maintenance of peripheral
immune tolerance [38]. Foxp3 has been demonstrated as a
specific marker for CD4+CD25+ regulatory T cells [39,40].
The frequency of CD4+CD25+Foxp3+T cells in splenocytes
was significantly increased in ACAID [16]. In this study, we
examined the frequency of these regulatory T cells in mice
with or without penetrating ocular injury during the
development of ACAID. It was found that the frequency of
CD4+CD25+Foxp3+T cells in the AC-injection group was
significantly increased, which was similar to the results
reported by Zhu et al. [16]. However, the frequency of
CD4+CD25+Foxp3+T cells was not increased in mice with
penetrating ocular injury 24 h or 48 h following an AC
injection of antigen. This result suggests that a penetrating
ocular injury at an early stage after an AC injection of OVA
does not alter the expression of CD4+CD25+Foxp3+T cells and
thereby does not result in the induction of ACAID.
In conclusion, our study revealed that a penetrating ocular
injury 24 h or 48 h after an AC injection of OVA could prevent
the development of ACAID. It is likely that downregulation
of TGF-β1, IL-10, and CD4+CD25+Foxp3+T cells and an
upregulation of IFN-γ contribute to this aborted ACAID.
However, our study did not answer the question as to how
these alterations occurred following a penetrating ocular
injury. We do not know whether the migration of tolerogenic
dendritic cells (DC) from the eye to the spleen is altered or
whether ocular DC are not tolerogenic due to the altered
microenvironment within the anterior chamber following a
penetrating ocular injury. It is also unclear whether other ways
of injury could influence ACAID induction. More studies are
needed to address these issues.
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